Trials / Completed
CompletedNCT05702190
Opium Tincture Against Chronic Diarrhea - Healthy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Asbjørn Mohr Drewes · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the mechanistic anti-propulsive effects of opium tincture on the gastrointestinal tract of a cohort of healthy participants.
Detailed description
Opium tincture is used a symptomatic drug against chronic diarrhea even though no clinical studies have investigated the effect on gastrointestinal function. With this randomized, double-blind, placebo-controlled cross-over trial in 20 healthy participants, the investigators wish to provide evidence-based insights into the effects of opium tincture on gastrointestinal function. Additionally, effects on the central nervous system will be investigated a tertiary aim.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Opium tincture | Self-administration of opium tincture (10 mg/ml) as 2x5 drops on day 1, 3x10 drops on days 2-8, and 1x10 drops on day 9 in each study period. |
| DRUG | Placebo | Self-administration of placebo as 2x5 drops on day 1, 3x10 drops on days 2-8, and 1x10 drops on day 9 in each study period. |
Timeline
- Start date
- 2021-03-09
- Primary completion
- 2022-06-01
- Completion
- 2022-06-01
- First posted
- 2023-01-27
- Last updated
- 2023-01-30
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05702190. Inclusion in this directory is not an endorsement.